Search

Events
MEMBERS
TOPICS
REGIONS
Rosenkranz Global Health Policy Research Symposium

Rosenkranz Global Health Policy Research Symposium

The 4th annual Rosenkranz Global Health Policy Research Symposium at Stanford University will be held on Tuesday, May 20, 2025. The Symposium is a day-long event that showcases innovative global health policy research from academics around the world. The keynote speaker will be Sir Peter Piot, a prominent leader in global health policy and practice.

Virtual Forum: Global Infectious Disease Policy Priorities

Virtual Forum: Global Infectious Disease Policy Priorities

The ID Alliance’s Virtual Forum: Global Infectious Disease Policy Priorities held on February 12, 2025 brings together leaders from civil society, policymakers, and key stakeholders in global health to discuss pressing infectious disease challenges and set strategic policy priorities the global infectious disease community should strive towards for the future. The outcome of the discussions will contribute in shaping IDA’s Policy Strategy for 2025-2030. 

Global Health Security: The Intersection of Policy and Academia

Global Health Security: The Intersection of Policy and Academia

Join The Department of State’s Bureau of Global Health Security and Diplomacy for a virtual symposium to highlight potential areas of collaboration between U.S. schools of public health and the State Department to advance global health security and end HIV/AIDS as a public health threat by 2030. This symposium provides opportunities for leaders of U.S. schools of public health to join in discussing future collaboration, with two main symposium topics: Panel 1: How Can Public Health Practitioners Influence Policy? and Panel 2: Global Public Health Institutions at the Intersection of Public Health and Diplomacy. 

Stanford Byers Center for Biodesign Policy Fellows’ Research Presentations

Stanford Byers Center for Biodesign Policy Fellows’ Research Presentations

Join Alliance member Stanford Institute for Biodesign for their Policy Fellows’ Research Presentations. Their inaugural policy fellows will be showcasing their work on Healthcare AI Policy for Trustworthy Innovation, Interoperability and Maternal Health, Implications of Current Policies in the Biotechnology Industry and Patient Care, and Medicare Adoption Rate of Novel Medical Devices.

Policy Briefing: Are We at a Change Moment? | June 8, 2021

Policy Briefing: Are We at a Change Moment? | June 8, 2021

A virtual Policy Briefing with Chris Collins, President and CEO of Friends of the Global Fight and formerly with UNAIDS, amfAR, and Rep. Nancy Pelosi. This year has been described as a year of great transition, but what’s actually happening? What have we learned from COVID and what are the plans on the table to react to that — in the US and elsewhere? Are we going to continue to under invest in global health or are we truly at a “change moment”?

Policy Briefing with Global Health Council’s President and CEO Elisha Dunn-Georgiou | October 19, 2021

Policy Briefing with Global Health Council’s President and CEO Elisha Dunn-Georgiou | October 19, 2021

Elisha Dunn-Georgiou, the new President and CEO of Global Health Council, joined us for a conversation and update on policy and funding issues on Capitol Hill, at UNGA and following President Biden’s recent COVID Summit, where she joined leaders in committing to end the COVID-19 pandemic. She gave her observations from DC and answered questions on the political state of global health, in this critical time.

Policy Briefing: Update From DC | October 13, 2022

Policy Briefing: Update From DC | October 13, 2022

On October 13, the Bay Area Global Health Alliance and the Center for Global Health Innovation brought together premier global health advocacy organizations Global Health Council, Global Health Technologies Coalition, and Friends of the Global Fight Against AIDS, Tuberculosis, and Malaria to update members on the US government’s global health budget, the impact of the pandemic on policy, new initiatives to spur innovation, and how to elevate equity in the global health agenda. Learn more.